EISMEA's Therapeutics Portfolio

Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

ChemoTech is an innovator in gentle cancer treatment and effective pain management.

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.

Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease

ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

AFYX Therapeutics is a clinical stage biopharmaceutical company

Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs